Compounds with activity of autophagy regulation have been identified to delay the AD pathology process, and inhibition of mTOR could increase Aβ1–42 clearance and rescue memory impairment in AD model mice via enhancing autophagy [27], [37]. This evidence concerns the gene MTOR and Alzheimer disease.